| Name | Galunisertib (LY2157299) | CAS# | 700874-72-2 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
LY2157299 is a potent TGFβ receptor I (TβRI) inhibitor with IC50 of 56 nM. Phase 2. |
Get all suppliers by the below link:
Galunisertib (LY2157299) suppliers
| 2024-07-15 |
LY2157299
Price: Inquiry |
| 2020-01-06 |
LY2157299(Galunisertib)
Price: $300.0 |
| 2025-09-17 |
Galunisertib (LY2157299)
Price: ¥Inquiry |
| 2017-12-15 |
4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide
Price: ¥Inquiry |
| 2021-05-10 |
LY 2157299
Price: ¥Inquiry |
| 2017-11-18 |
4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide
Price: ¥Inquiry |
| 2019-03-19 |
Galunisertib
Price: ¥Inquiry |
| 2018-04-16 |
Galunisertib
Price: ¥Inquiry |
| 2023-08-21 |
Galunisertib
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


